Cite
HARVARD Citation
Keehn, A. et al. (2016). Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer. Future oncology. pp. 2673-2682. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Keehn, A. et al. (2016). Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer. Future oncology. pp. 2673-2682. [Online].